Jay M. Wendling

1.2k total citations
18 papers, 714 citations indexed

About

Jay M. Wendling is a scholar working on Health, Toxicology and Mutagenesis, Molecular Biology and Surgery. According to data from OpenAlex, Jay M. Wendling has authored 18 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Health, Toxicology and Mutagenesis, 3 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Jay M. Wendling's work include Toxic Organic Pollutants Impact (7 papers), Effects and risks of endocrine disrupting chemicals (3 papers) and Analytical Chemistry and Chromatography (2 papers). Jay M. Wendling is often cited by papers focused on Toxic Organic Pollutants Impact (7 papers), Effects and risks of endocrine disrupting chemicals (3 papers) and Analytical Chemistry and Chromatography (2 papers). Jay M. Wendling collaborates with scholars based in United States, Israel and Poland. Jay M. Wendling's co-authors include Fred D. Hileman, Xiao Hu, Robert G. Orth, James D. Wilson, Peter L. Toogood, Xikui Liu, Rodney Morgan, Gary D. Glick, Brian Sanchez and Ling-Yang Hao and has published in prestigious journals such as Analytical Chemistry, Chemosphere and Journal of Medicinal Chemistry.

In The Last Decade

Jay M. Wendling

18 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay M. Wendling United States 11 299 138 112 98 79 18 714
Pengli Bu United States 17 500 1.7× 66 0.5× 124 1.1× 136 1.4× 77 1.0× 29 946
James Diguiseppi United States 7 557 1.9× 75 0.5× 53 0.5× 123 1.3× 83 1.1× 7 1.1k
Wei Fu China 14 408 1.4× 47 0.3× 104 0.9× 135 1.4× 49 0.6× 38 847
Laurie Tsuruda United States 14 576 1.9× 172 1.2× 48 0.4× 130 1.3× 35 0.4× 20 1.2k
Tammie McQuistan United States 17 651 2.2× 70 0.5× 179 1.6× 73 0.7× 69 0.9× 20 1.2k
Adrian Nañez United States 10 602 2.0× 111 0.8× 50 0.4× 146 1.5× 57 0.7× 16 942
Éric Badia France 18 534 1.8× 70 0.5× 66 0.6× 89 0.9× 50 0.6× 46 1.0k
Ron Pinkus Israel 7 726 2.4× 79 0.6× 195 1.7× 104 1.1× 48 0.6× 8 1.1k
Quentin Felty United States 17 604 2.0× 187 1.4× 93 0.8× 212 2.2× 29 0.4× 49 1.2k
Hirochika Kitagawa Japan 14 859 2.9× 336 2.4× 161 1.4× 175 1.8× 89 1.1× 17 1.6k

Countries citing papers authored by Jay M. Wendling

Since Specialization
Citations

This map shows the geographic impact of Jay M. Wendling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay M. Wendling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay M. Wendling more than expected).

Fields of papers citing papers by Jay M. Wendling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay M. Wendling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay M. Wendling. The network helps show where Jay M. Wendling may publish in the future.

Co-authorship network of co-authors of Jay M. Wendling

This figure shows the co-authorship network connecting the top 25 collaborators of Jay M. Wendling. A scholar is included among the top collaborators of Jay M. Wendling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay M. Wendling. Jay M. Wendling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liston, Theodore E., Sonja Hinz, Christa E. Müller, et al.. (2020). Nucleotide P2Y1 receptor agonists are in vitro and in vivo prodrugs of A1/A3 adenosine receptor agonists: implications for roles of P2Y1 and A1/A3 receptors in physiology and pathology. Purinergic Signalling. 16(4). 543–559. 19 indexed citations
2.
Hu, Xiao, Yahong Wang, Ling-Yang Hao, et al.. (2015). Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists. Nature Chemical Biology. 11(2). 141–147. 176 indexed citations
3.
Li, Xing, Bruce C. Hamper, Theresa Fletcher, et al.. (2010). Structure-based parallel medicinal chemistry approach to improve metabolic stability of benzopyran COX-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(3). 993–996. 9 indexed citations
4.
Gierse, James K., Atli Thorarensen, Erica L. Bradshaw‐Pierce, et al.. (2010). A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation. Journal of Pharmacology and Experimental Therapeutics. 334(1). 310–317. 181 indexed citations
5.
Kahn, Larry E., Hideaki Shimada, Ben S. Zweifel, et al.. (2010). Biochemical, Cellular, and Anti-Inflammatory Properties of a Potent, Selective, Orally Bioavailable Benzamide Inhibitor of Rho Kinase Activity. Journal of Pharmacology and Experimental Therapeutics. 333(3). 707–716. 8 indexed citations
6.
7.
Obukowicz, Mark G., et al.. (1998). Identification and Characterization of a Novel Δ6/Δ5 Fatty Acid Desaturase Inhibitor As a Potential Anti-Inflammatory Agent. Biochemical Pharmacology. 55(7). 1045–1058. 48 indexed citations
8.
Aggarwal, Suresh K., Robert G. Orth, Jay M. Wendling, Michael Kinter, & David A. Herold. (1993). Isotope Dilution Gas Chromatography/Mass Spectrometry for Cadmium Determination in Urine. Journal of Analytical Toxicology. 17(1). 5–10. 5 indexed citations
9.
Wendling, Jay M., Robert G. Orth, & H. Poiger. (1990). Determination of [3H]-2,3,7,8-tetrachlorodibenzo-p-dioxin in human feces to ascertain its relative metabolism in man. Analytical Chemistry. 62(8). 796–800. 23 indexed citations
10.
Hon-Wing, Leung, Jay M. Wendling, Robert G. Orth, Fred D. Hileman, & Dennis J. Paustenbach. (1990). Relative distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin human hepatic and adipose tissues. Toxicology Letters. 50(2-3). 275–282. 26 indexed citations
11.
Wendling, Jay M., Ronald Orth, H. Poiger, & Fred D. Hileman. (1990). Methodology for the analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin in feces. Chemosphere. 20(3-4). 343–347. 2 indexed citations
12.
Wendling, Jay M., Fred D. Hileman, Robert G. Orth, et al.. (1989). An analytical assessment of the bioavailability of dioxin contaminated soils to animals. Chemosphere. 18(1-6). 925–932. 13 indexed citations
13.
Hileman, Fred D., et al.. (1989). An evaluation of the molecular structure of octachlorodibenzofuran. Chemosphere. 18(1-6). 1039–1046. 9 indexed citations
14.
Hileman, Fred D., et al.. (1989). Dibenzofuran in diphenyl oxide and the relationship to brominated dibenzofurans in brominated diphenyl oxide. Chemosphere. 18(1-6). 217–224. 6 indexed citations
15.
Hileman, Fred D., et al.. (1986). Chlorocarbons in adipose tissue from a Missouri population. Chemosphere. 15(9-12). 1595–1600. 41 indexed citations
16.
Hileman, Fred D., et al.. (1985). Background human exposure to 2,3,7,8-TCDD. Chemosphere. 14(6-7). 925–928. 41 indexed citations
17.
Wendling, Jay M., et al.. (1981). The early stages of development in Carcharhinus plumbeus. Journal of Fish Biology. 18(2). 159–175. 28 indexed citations
18.
Pourel, J, et al.. (1970). [Parietal disc ossifications].. PubMed. 36(7). 373–81. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pengli Bu Breakdown of academic impact, for papers by James Diguiseppi Breakdown of academic impact, for papers by Wei Fu Breakdown of academic impact, for papers by Laurie Tsuruda Breakdown of academic impact, for papers by Tammie McQuistan Breakdown of academic impact, for papers by Adrian Nañez Breakdown of academic impact, for papers by Éric Badia Breakdown of academic impact, for papers by Ron Pinkus Breakdown of academic impact, for papers by Quentin Felty Breakdown of academic impact, for papers by Hirochika Kitagawa
Rankless by CCL
2026